Melanoma
Genzyme announces clinical data from melanoma vaccine trial
Published in Gene Therapy Weekly, June 26th, 2003
The findings from the study were presented at the annual American Society of Clinical Oncology (ASCO) conference in Chicago.
Frank G. Haluska, MD, PhD, at the Massachusetts General Hospital Cancer Center, was the lead investigator of the phase I/II trial and presented the clinical results.
"Data from this clinical trial further demonstrate that vaccine immunization approaches in cancer can be safe and effective in creating measurable immune responses in some patients with melanoma," stated Haluska. "While there are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-06-26)
More Articles from Gene Therapy Weekly
- Graft Rejection
Nonmyeloablative conditioning improves acceptance of gene-modified cells - Toxicology
Existing assays are not sufficient for evaluating DNA-based product toxicity - Atherosclerosis
MCP-1 is an attractive target for the prevention of arterial restenosis - Gene Silencing
Single-strand and double-strand short interfering RNAs have common pathways - Mesothelioma
Intratumoral gene transfer might stem the growth of asbestos-related cancer - Type 1 Diabetes
Tetracycline moderates insulin secretion from transfected myoblasts - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
